Description: TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.
Home Page: trisaluslifesci.com
6272 West 91st Avenue
Westminster,
CO
80031
United States
Phone:
303 442 1222
Officers
| Name | Title |
|---|---|
| Ms. Mary T. Szela B.S.N., M.B.A. | CEO, President & Director |
| Mr. Sean Edward Murphy | CFO & Director |
| Ms. Lori Ann Santamaria | Vice President of Operations |
| Dr. Bryan F. Cox Ph.D. | Chief Scientific & Manufacturing Officer |
| Mr. James E. Young | Senior VP of Investor Relations & Treasurer |
| Dr. Richard B. Marshak M.B.A., MBA, VMD | Senior Vice President of Corporate Development & Strategy |
| Ms. Jennifer L. Stevens J.D. | Chief Regulatory Officer |
| Ms. Jodi Devlin | President of Commercial Operations |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 30.2854 |
| Price-to-Sales TTM: | 4.82 |
| IPO Date: | 2023-08-10 |
| Fiscal Year End: | December |
| Full Time Employees: | 107 |